The Centers for Disease Control and Prevention endorsed a committee's recommendation that the Novavax COVID-19 vaccine be used as a primary series option for adults.
Following the endorsement by the U.S. CDC, Novavax (NVAX) can now start immunizations with its COVID-19 vaccine as a primary two-dose regimen for use in adults in the United States.
There is good news for the company, but there is more work to do ahead.
The U.S. Centers for Disease Control and Prevention authorized the Novavax vaccine for adults late Tuesday, clearing the final obstacle to the use of a fourth alternative and one that is based on more
They're not easy tasks. But Novavax could potentially achieve them.
The Covid-19 vaccine from Novavax is the fourth approved for use in the United States.
CNBC's Shep Smith reports that a panel of CDC advisors voted unanimously today to recommend the vaccine developed by Novavax, a vaccine made with more traditional technology.
U.S. adults who haven't gotten any COVID-19 shots yet should consider a new option from Novavax — a more traditional kind of vaccine, health officials said Tuesday.

CDC Panel Endorses Novavax, a New COVID Vaccine

05:54pm, Tuesday, 19'th Jul 2022
The CDC's director is expected to accept the recommendation, which will make Novavax available to adults who haven't been vaccinated yet.
The CDC has unanimously recommends Novavax's latest COVID-19 booster vaccine for adults, awaiting the director's final approval
Shares of Novavax Inc. NVAX, +14.32% jumped 11.9% in trading on Tuesday after the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices voted in favor of the compan
The recommendation from the CDC's Advisory Committee on Immunization Practices heads to CDC director Rochelle Walensky for approval.
Novavax has several catalysts igniting NVAX stock higher today. The bulls hope this is just the beginning for NVAX shares.
Novavax uses different technology than Pfizer and Moderna. U.S. health officials hope Novavax's shots might convince skeptics to get vaccinated.

Why Novavax Stock Is Surging Today

02:34pm, Tuesday, 19'th Jul 2022
Novavax Inc (NASDAQ: NVAX) shares are trading higher Tuesday as CDC advisers meet to discuss the company's COVID-19 vaccine. Novavax also announced agreements with SK bioscience for the manufacturi
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE